Ocelot Bio
ocelotbio.comOcelot Bio is a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics designed to significantly improve outcomes for patients with liver disease. The company’s lead clinical candidate, OCE-205, is a therapeutic peptide with a mechanism of action designed to selectively target complications of portal hypertension, such as hepatorenal syndrome with acute kidney injury (HRS-AKI), a serious and life-threatening consequence of end-stage liver disease.
Something looks off?Open jobs at Ocelot Bio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.